Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Kesterson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lab Animal|August 29, 2023
The problem with repurposing genetically modified organismsRobert Kesterson, Elizabeth Floyd
Cardiovascular Research|February 8, 2017
Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in miceYin Peng, Lanying Song, Ding Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2020
CHD7 regulates cardiovascular development through ATP-dependent and -independent activitiesShun Yan, Rassarin Thienthanasit, Dongquan Chen, et al.
Clinical Trials (London, England)|November 8, 2023
Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trialsVerena Staedtke, Kara Anstett, David Bedwell, et al.
The Hastings Center Report|December 9, 2022
Clarifying the Ethics and Oversight of Chimeric ResearchJosephine Johnston, Insoo Hyun, Carolyn P Neuhaus, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lab Animal|August 29, 2023
The problem with repurposing genetically modified organismsRobert Kesterson, Elizabeth Floyd
Cardiovascular Research|February 8, 2017
Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in miceYin Peng, Lanying Song, Ding Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2020
CHD7 regulates cardiovascular development through ATP-dependent and -independent activitiesShun Yan, Rassarin Thienthanasit, Dongquan Chen, et al.
Clinical Trials (London, England)|November 8, 2023
Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trialsVerena Staedtke, Kara Anstett, David Bedwell, et al.
The Hastings Center Report|December 9, 2022
Clarifying the Ethics and Oversight of Chimeric ResearchJosephine Johnston, Insoo Hyun, Carolyn P Neuhaus, et al.
Pageof 1